Talk about an embarrassment of riches. Dupont Circle hosts blocks and blocks of award-winning restaurants and chefs, many of whom are classically trained but also inclined to put their own ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

DuPont is adjusting its plan to split into three separate companies. Eight months after releasing its plan to spin off into three multibillion-dollar divisions, the company announced that only one ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

GENEVA, Switzerland, Jan. 21, 2025 /PRNewswire/ -- DuPont (NYSE: DD ... MOLYKOTE ® developed an innovative lubricant testing protocol aligned with these standards. The grease underwent several ...

today announced that DuPont ™ MOLYKOTE ® HP-300 Grease has successfully met rigorous hydrogen purity standards in accordance with ISO 14687:2019. In collaboration with HyCentA Research GmbH, MOLYKOTE ...